- Home
- AWRE vs ABVC Comparison
AWRE vs ABVC Comparison
Compare AWRE & ABVC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AWRE
- ABVC
- Stock Information
- Founded
- AWRE 1986
- ABVC 2015
- Country
- AWRE United States
- ABVC United States
- Employees
- AWRE N/A
- ABVC N/A
- Industry
- AWRE Computer Software: Prepackaged Software
- ABVC Biotechnology: Pharmaceutical Preparations
- Sector
- AWRE Technology
- ABVC Health Care
- Exchange
- AWRE Nasdaq
- ABVC Nasdaq
- Market Cap
- AWRE 50.3M
- ABVC 52.1M
- IPO Year
- AWRE 1996
- ABVC N/A
- Fundamental
- Price
- AWRE $2.44
- ABVC $3.30
- Analyst Decision
- AWRE
- ABVC
- Analyst Count
- AWRE 0
- ABVC 0
- Target Price
- AWRE N/A
- ABVC N/A
- AVG Volume (30 Days)
- AWRE 45.1K
- ABVC 223.6K
- Earning Date
- AWRE 07-30-2025
- ABVC 08-13-2025
- Dividend Yield
- AWRE N/A
- ABVC N/A
- EPS Growth
- AWRE N/A
- ABVC N/A
- EPS
- AWRE N/A
- ABVC N/A
- Revenue
- AWRE $16,146,999.00
- ABVC $391,242.00
- Revenue This Year
- AWRE N/A
- ABVC $735.18
- Revenue Next Year
- AWRE N/A
- ABVC N/A
- P/E Ratio
- AWRE N/A
- ABVC N/A
- Revenue Growth
- AWRE N/A
- ABVC 186.84
- 52 Week Low
- AWRE $1.35
- ABVC $0.40
- 52 Week High
- AWRE $2.68
- ABVC $5.48
- Technical
- Relative Strength Index (RSI)
- AWRE 60.96
- ABVC 56.53
- Support Level
- AWRE $2.29
- ABVC $2.90
- Resistance Level
- AWRE $2.52
- ABVC $3.06
- Average True Range (ATR)
- AWRE 0.17
- ABVC 0.28
- MACD
- AWRE 0.00
- ABVC 0.00
- Stochastic Oscillator
- AWRE 82.50
- ABVC 91.92
About AWRE Aware Inc.
Aware Inc is a provider of software and services to the biometrics industry. The company's software products are used in government and commercial biometrics systems to identify or authenticate people. The government applications of biometrics systems include border control, visa applicant screening, law enforcement, national defense, intelligence, secure credentialing, access control, and background checks. Its commercial applications include user authentication for login to mobile devices, computers, networks, and software programs, user authentication for financial transactions and purchases. Its geographical segments include the United States, the United Kingdom, and the Rest of the world, out of which it derives maximum revenue from United States.
About ABVC ABVC BioPharma Inc.
ABVC BioPharma Inc is a clinical-stage biopharmaceuticals company with an active pipeline of six drugs and one medical device (ABV-1701/Vitargus) under development. Its drug products focus on utilizing its licensed technology to conduct proof-of-concept trials through Phase II of the clinical development process. The firm specializes in botanically based solutions that deliver high efficacy with low toxicity for improved health outcomes.